Press for TearScience
TearScience®, Inc., a privately-held medical device company, today announced the promotion of Nicole Wicker to chief financial officer (CFO). Nicole has served as TearScience’s vice president of finance since joining the company in December, 2008.
TearScience®, a privately held medical device company, today announced that it sponsored research for seven scientific posters on evaporative dry eye and its technology, at the 2012 Association for Research in Vision and Ophthalmology (ARVO) annual meeting being held from May 6-10, 2012, in Fort Lauderdale, Florida. Subjects reflect new, ongoing research on the disease, TearScience®’s technology, and clinical outcomes. The posters cover topics such as how the LipiFlow® Thermal Pulsation System can rejuvenate Meibomian gland secretions for up to a year as well as LipiFlow’s efficacy and safety over warm compress therapy for treating Meibomian gland dysfunction. Another demonstrates LipiView Ocular Surface Interferometer’s ability to consistently and accurately measure the thickness of thin film, optically similar to the tear film. Additional research presented increases the general understanding of normal Meibomian gland function and eye lid physiology and interaction.